ASCO 2024: New ultra-sensitive blood test predicts recurrence of breast cancer, months or even years before relapse 01 Jun 2024 A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, London, has shown. Find out more Show/Hide
Blood tests may prevent relapse in breast cancer patients 18 Nov 2022 An innovative trial to detect relapse in breast cancer patients with circulating tumour DNA (ctDNA) has opened at our partner hospital, The Royal Marsden NHS Foundation Trust. The TRAK-ER trial, led by researchers at The Royal Marsden and The Institute of Cancer Research, London, will establish a circulating tumour DNA (ctDNA) surveillance programme for over 1,000 patiets with ER positive breast cancer who are currently receiving hormone therapy to reduce their risk of cancer returning. Find out more Show/Hide